Risk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs
- PMID: 10950539
- PMCID: PMC1118171
Risk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs
Comment on
-
Guidelines on preventing cardiovascular disease in clinical practice.BMJ. 2000 Mar 11;320(7236):659-61. doi: 10.1136/bmj.320.7236.659. BMJ. 2000. PMID: 10710556 Free PMC article. No abstract available.
-
Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?BMJ. 2000 Mar 11;320(7236):677-9. doi: 10.1136/bmj.320.7236.677. BMJ. 2000. PMID: 10710575 Free PMC article. No abstract available.
-
Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated.BMJ. 2000 Mar 11;320(7236):680-5. doi: 10.1136/bmj.320.7236.680. BMJ. 2000. PMID: 10710577 Free PMC article.
References
-
- LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: meta-analysis of randomized controlled trials. JAMA. 1999;282:2340–2346. - PubMed
-
- West of Scotland Coronary Prevention Group. West of Scotland coronary prevention study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996;348:1339–1342. - PubMed
-
- Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA. 1998;279:1615–1622. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical